6533b833fe1ef96bd129b8a1

RESEARCH PRODUCT

Behavior of the total antioxidant status in a group of subjects with metabolic syndrome.

Maria MontanaGregorio CaimiEugenia HoppsMaurizio AvernaBaldassare CaninoRosalia Lo Presti

subject

AdultBlood GlucoseMalemedicine.medical_specialtyanimal structuresAntioxidantSettore MED/09 - Medicina InternaBilirubinEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBlood PressureAntioxidantschemistry.chemical_compoundInternal medicineDiabetes mellitusInternal MedicinemedicineHumansAgedMetabolic SyndromeABTSbusiness.industryBilirubinGeneral MedicineMiddle Agedmedicine.diseasePathophysiologyTOTAL ANTIOXIDANT STATUS METABOLIC SYNDROMEUric AcidAntioxidant capacityOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2ItalyLinear ModelsUric acidFemaleMetabolic syndromebusiness

description

AIM: Our purpose was to examine the total antioxidant status (TAS) in subjects with metabolic syndrome (MS) subdivided according to the presence or not of diabetes mellitus. METHODS: We enrolled 106 subjects (45 women, 61 men) with MS subsequently subdivided in diabetics (14 women, 29 men) and nondiabetics (31 women, 29 men). TAS was obtained using an Assay kit which relies on the ability of plasma antioxidant substances to inhibit the oxidation of 2,2'-azino-bis(3-ethylbenzthiazoline sulfonic acid) to the radical ABTS+. RESULTS: In the group of MS subjects a significant decrease in TAS (p<0.05) in comparison with normal controls was evident. This difference was present between normal subjects and nondiabetic subjects with MS (p<0.001) but not between normal and diabetic subjects with MS. Examining the linear regression among TAS, age, anthropometric profile, blood pressure values and glycometabolic pattern, conflicting data were found. CONCLUSIONS: Although we know that TAS includes several enzymatic and non enzymatic antioxidants, we retain that the difference observed in the two subgroups of subjects with MS must be looked in particular into two pathophysiological aspects regarding bilirubin and uric acid.

10.1016/j.dsx.2014.04.013http://hdl.handle.net/10447/98683